Skip to main content
. 2020 Sep 14;22(6):1523–1531. doi: 10.1007/s11307-020-01523-7

Fig. 2.

Fig. 2.

In vivo (BALB/C) emission spectra for different combinations of luciferase (Luc2, CBG99, CBR2, or Akaluc; expressed in HEK393T cells implanted subcutaneously in the flanks) and luciferin or luciferin analogue. (a) D-LH2 (150 mg/kg), (b) NH2-NpLH2 (220 mg/kg), (c) CycLuc1 (7.6 mg/kg), and (d) Akalumine-HCl (50 mg/kg); substrates were injected intraperitoneally). Spectral data was acquired 15–20 min after injection.